Organization
Department of Medical Oncology, the Fifth Medical Center, Chinese PLA General Hospital
1 abstract
Abstract
Efficacy and safety of immune checkpoint inhibitor without pemetrexed for first-line maintenance therapy in advanced lung adenocarcinoma.Org: Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”, Meldola, Italy, Italy, The Fifth Medical Center of PLA General Hospital, School of Medicine, Nankai University, The First Medical Center of PLA General Hospital, Department of Oncology, the First Medical Center, Chinese PLA General Hospital,